title: Acute orbitocranial inflammation following radioimmunotherapy for non-Hodgkin lymphoma.
abstract: Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan may result in hemorrhagic tumor necrosis with acute orbital and intracranial inflammation.
authors.affiliation: Edward S. Harkness Eye Institute, Columbia University Medical Center, New York, New York 10032, USA.
authors.forename: John C
authors.initials: JC
authors.lastname: Hwang
authors.forename: Tarek
authors.initials: T
authors.lastname: El-Sawy
authors.forename: Christopher I
authors.initials: CI
authors.lastname: Zoumalan
authors.forename: Jasmine
authors.initials: J
authors.lastname: Zain
authors.forename: Owen A
authors.initials: OA
authors.lastname: O'Connor
authors.forename: Michael
authors.initials: M
authors.lastname: Kazim
mesh_terms: D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018951:Antigens, CD20; D004660:Encephalitis / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000473:pathology / Q000532:radiotherapy*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D054517:Orbital Cellulitis / Q000175:diagnosis / Q000209:etiology*; D009918:Orbital Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D016499:Radioimmunotherapy / Q000009:adverse effects*; D015021:Yttrium Radioisotopes
chemical_list: D000911:Antibodies, Monoclonal; D018951:Antigens, CD20; D015021:Yttrium Radioisotopes; C422802:ibritumomab tiuxetan